Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 755 of 6351
-
Could a bigger balloon tame the Heart's electrical chaos?
Disease control OngoingApproximately 40% of patients following cryoballoon ablation show signs of parasympathetic denervation. The presence of such effect is related to better outcomes in terms of clinical efficacy (freedom from atrial fibrillation). It could be hypothesized that larger sized balloon (…
Sponsor: Wroclaw Medical University • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
New blood pressure drug aims for Round-the-Clock control
Disease control CompletedA multicenter, randomized, double-blind, phase III study to evaluate efficacy and safety of HGP2304 in patients with essential hypertension
Phase 3 • Sponsor: Hanmi Pharmaceutical Company Limited • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Heart-Guided exercise may keep aging bodies stronger
Prevention CompletedThis study was conducted in collaboration with a community-based retirement facility to evaluate the clinical effectiveness of a smart, technology-assisted circuit exercise intervention for community-dwelling older adults. Traditional exercise prescriptions for older adults often…
Sponsor: Chang Gung Memorial Hospital • Aim: Prevention
Last updated Aug 29, 2026 00:00 UTC
-
Could CAR t cells unlock transplants for 'Impossible to Match' kidney patients?
Disease control Recruiting nowThis research study is for people who have been waiting for a kidney transplant for at least one year, and who have a cPRA of 99.5% or higher. Having a cPRA of 99.5% or higher means that your immune system would reject 99.5% of kidneys available for transplant. The study will tes…
Phase 1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New gene therapy combo aims to keep advanced lung cancer in check
Disease control Recruiting nowThis clinical trial will evaluate the combination of quaratusugene ozeplasmid with atezolizumab as maintenance therapy for patients with Extensive Stage Small Cell Lung Cancer (ES-SCLC). The study is comprised of 2 phases, a dose selection phase (Phase 1) and a safety and effica…
Phase 1/2 • Sponsor: Genprex, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Could a Lower-Dose polio vaccine help eradicate the disease?
Vaccine CompletedIn 2012, the World Health Assembly (WHA) endorsed the proposed Polio Endgame Strategy, which includes withdrawal of the Sabin-virus type 2 antigen-responsible for an estimated 95% of vaccine derived cases of polio by replacing the trivalent Oral Polio Vaccine (OPV) in the routine…
Phase 3 • Sponsor: Serum Institute of India Pvt. Ltd. • Aim: Vaccine
Last updated Jul 03, 2026 00:00 UTC
-
Could a tiny tube spare preterm babies from breathing machines?
Disease control Recruiting nowThe aim of this study is to see if giving less invasive surfactant administration (LISA) during high-flow nasal cannula (HFNC) oxygen treatment reduces the need for invasive ventilation in babies with breathing problems born 2-6 weeks early. Less invasive surfactant administrati…
Sponsor: King's College Hospital NHS Trust • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Could a diet and drug combo replace the knife for severe obesity?
Disease control Recruiting nowWith this trial, the aim is to assess the benefits and harms of a non-surgical intensive weight loss intervention that includes total dietary replacements, behavioural support and weight-loss medication compared with bariatric surgery for people with severe and complex obesity. T…
Sponsor: Carsten Dirksen • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Can immune therapy IVIG calm long COVID's autonomic storm?
Disease control CompletedThis study is a platform protocol designed to be flexible so that it is suitable for a wide range of settings within health care systems and in community settings where it can be integrated into COVID-19 programs and subsequent treatment plans. This protocol is a prospective, mu…
Phase 2 • Sponsor: Kanecia Obie Zimmerman • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Eczema drug shows promise in keeping skin clear for a year
Disease control OngoingThis is a multinational, multicenter, randomized, double-blind, placebo-controlled, parallel, Phase 3 study for treatment of participants aged 12 years and older diagnosed with moderate-to-severe atopic dermatitis (AD). The primary objective of ESTUARY is to assess the maintenan…
Phase 3 • Sponsor: Sanofi • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Can a sedative stop deadly heart storms?
Symptom relief Recruiting nowThe objective of this study is to determine if there is a meaningful benefit to using the sedative medication dexmedetomidine in the acute treatment of patients with recurrent ventricular arrhythmias, known as electrical storm. This will be a multi-centre, double-blinded, placebo…
Phase 3 • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Symptom relief
Last updated Jul 09, 2026 00:00 UTC
-
New trial aims to boost colon cancer treatment by giving chemo before surgery
Disease control Recruiting nowThe aim of this study is to determine whether chemotherapy prior to tumor removal (neoadjuvant chemotherapy), in patients undergoing treatment for colon cancer in occlusion (CCO), would improve the rate of patients able to benefit from "optimal" treatment, i.e. complete treatment…
Phase 3 • Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Mind over movement: Brain-Controlled therapy aims to restore walking after spinal injury
Disease control Recruiting nowThe purpose of this research is to test the effectiveness of a new therapy, called Brain-Computer Interface (BCI)-Transcutaneous Spinal Cord Stimulation (TSCS), for improving walking in people with an incomplete spinal cord injury (SCI).
Sponsor: University of Miami • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
New drug combo aims to shrink HER2-Positive tumors
Disease control Recruiting nowThis phase II ComboMATCH treatment trial compares the effect of neratinib to the combination of neratinib and palbociclib in treating patients with HER2 positive solid tumors. Neratinib and palbociclib are in a class of medications called kinase inhibitors. They work by blocking …
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 10, 2026 08:00 UTC
-
New counseling approach aims to curb youth suicide risk
Symptom relief Recruiting nowThe goal of this RCT study is to test the efficacy of a stratified stepped-care (SSC) model in reducing suicidal thoughts and behaviors (STB) in children and adolescents. The main questions it aims to answer are: 1. Does the SSC model effectively reduce STB and mental health sym…
Sponsor: Shira Barzilay • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
Could a single friendly gut bacterium prevent recurrent c. diff?
Prevention Recruiting nowClostridioides difficile infection (CDI) is the leading cause of nosocomial diarrhea in Europe, with over 120,000 cases and almost 3,700 deaths per year. This infection is characterized by a high risk of recurrence after cure, ranging from almost 20% after a first episode to over…
Phase 1/2 • Sponsor: Hospices Civils de Lyon • Aim: Prevention
Last updated Aug 13, 2026 00:00 UTC
-
Can your apple watch spot hidden heart disease? mayo clinic study says AI might help.
Diagnosis OngoingThe purpose of this study is to evaluate the AI-ECG algorithm for HCM in detecting HCM and in differentiating it from athlete's using not only the standard 12-lead ECG, but also ECGs obtained with the Apple Watch and Alivecor KardiaMobile devices.
Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Jun 27, 2026 11:03 UTC
-
Massive trial aims to slash infection risk in hip and knee replacements
Prevention Recruiting nowOsteoarthritis (OA) is the most common cause of disability in older adults worldwide affecting 7% of the global population, or more than 500 million people globally. Total joint replacements (TJR) can help bring relief to those with osteoarthritis when other treatment options are…
Phase 3 • Sponsor: Hamilton Health Sciences Corporation • Aim: Prevention
Last updated Jun 27, 2026 12:37 UTC
-
Can an antidepressant soothe both mind and gut?
Disease control CompletedThis study will test whether it is feasible to conduct a clinical trial of mirtazapine (an antidepressant tablet) in patients who have both depression and inflammatory bowel disease (IBD). The study design is a randomised controlled trial (a study in which people are allocated by…
Phase 2 • Sponsor: King's College London • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Custom immune cells take on multiple cancers in early trial
Disease control OngoingTScan Therapeutics is developing cellular therapies across multiple solid tumors in which autologous participant-derived engeneered T cells are engineered to express a T cell receptor that recognizes cancer-associated antigens presented on specific Human Leukocyte Antigen (HLA) m…
Phase 1 • Sponsor: TScan Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC